|
1
|
Allison DC, Carney SC, Ahlmann ER,
Hendifar A, Chawla S, Fedenko A, Angeles C and Menendez LR: A
meta-analysis of osteosarcoma outcomes in the modern medical era.
Sarcoma. 2012:7048722012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang J and Zhang W: New molecular insights
into osteosarcoma targeted therapy. Curr Opin Oncol. 25:398–406.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kato H, Wakabayashi H, Naito Y, Kato S,
Nakagawa T, Matsumine A and Sudo A: Anti-tumor necrosis factor
therapy inhibits lung metastasis in an osteosarcoma cell line.
Oncology. 88:139–146. 2015.
|
|
4
|
Li Y, Liao Q, Li K, Zhong D, Weng X and Mi
M: Knockdown of endothelin A receptor expression inhibits
osteosarcoma pulmonary metastasis in an orthotopic xenograft mouse
model. Mol Med Rep. 5:1391–1395. 2012.PubMed/NCBI
|
|
5
|
Zöller M: Tetraspanins: Push and pull in
suppressing and promoting metastasis. Nat Rev Cancer. 9:40–55.
2009. View
Article : Google Scholar
|
|
6
|
Li P, Zeng H, Qin J, Zou Y, Peng D, Zuo H
and Liu Z: Effects of tetraspanin CD151 inhibition on A549 human
lung adenocarcinoma cells. Mol Med Rep. 11:1258–1265. 2015.
|
|
7
|
Peng D, Zuo H, Liu Z, Qin J, Zhou Y, Li P,
Wang D, Zeng H and Zhang XA: The tetraspanin CD151-ARSA mutant
inhibits angiogenesis via the YRSL sequence. Mol Med Rep.
7:836–842. 2013.PubMed/NCBI
|
|
8
|
Copeland BT, Bowman MJ and Ashman LK:
Genetic ablation of the tetraspanin CD151 reduces spontaneous
metastatic spread of prostate cancer in the TRAMP model. Mol Cancer
Res. 11:95–105. 2013. View Article : Google Scholar
|
|
9
|
Zijlstra A, Lewis J, Degryse B, Stuhlmann
H and Quigley JP: The inhibition of tumor cell intravasation and
subsequent metastasis via regulation of in vivo tumor cell motility
by the tetraspanin CD151. Cancer Cell. 13:221–234. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sadej R, Romanska H, Kavanagh D, Baldwin
G, Takahashi T, Kalia N and Berditchevski F: Tetraspanin CD151
regulates transforming growth factor beta signaling: Implication in
tumor metastasis. Cancer Res. 70:6059–6070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takeda Y, Li Q, Kazarov AR, Epardaud M,
Elpek K, Turley SJ and Hemler ME: Diminished metastasis in
tetraspanin CD151-knockout mice. Blood. 118:464–472. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sadej R, Grudowska A, Turczyk L, Kordek R
and Romanska HM: CD151 in cancer progression and metastasis: A
complex scenario. Lab Invest. 94:41–51. 2014. View Article : Google Scholar
|
|
13
|
Zhang Z, Zhang L, Hua Y, Jia X, Li J, Hu
S, Peng X, Yang P, Sun M, Ma F, et al: Comparative proteomic
analysis of plasma membrane proteins between human osteosarcoma and
normal osteoblastic cell lines. BMC Cancer. 10:2062010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hoeppner LH, Secreto FJ and Westendorf JJ:
Wnt signaling as a therapeutic target for bone diseases. Expert
Opin Ther Targets. 13:485–496. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luu HH, Kang Q, Park JK, Si W, Luo Q,
Jiang W, Yin H, Montag AG, Simon MA, Peabody TD, et al: An
orthotopic model of human osteosarcoma growth and spontaneous
pulmonary metastasis. Clin Exp Metastasis. 22:319–329. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo X, Sharff KA, Chen J, He TC and Luu
HH: S100A6 expression and function in human osteosarcoma. Clin
Orthop Relat Res. 466:2060–2070. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su Y, Luo X, He BC, Wang Y, Chen L, Zuo
GW, Liu B, Bi Y, Huang J, Zhu GH, et al: Establishment and
characterization of a new highly metastatic human osteosarcoma cell
line. Clin Exp Metastasis. 26:599–610. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Z, Rebowe RE, Wang Z, Li Y, Wang Z,
DePaolo JS, Guo J, Qian C and Liu W: KIF3a promotes proliferation
and invasion via Wnt signaling in advanced prostate cancer. Mol
Cancer Res. 12:491–503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hong IK, Jin YJ, Byun HJ, Jeoung DI, Kim
YM and Lee H: Homophilic interactions of tetraspanin CD151
up-regulate motility and matrix metalloproteinase-9 expression of
human melanoma cells through adhesion-dependent c-Jun activation
signaling pathways. J Biol Chem. 281:24279–24292. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li M, Zhou W, Yuan R, Chen L, Liu T, Huang
D, Hao L, Xie Y and Shao J: ROCK2 promotes HCC proliferation by
CEBPD inhibition through phospho-GSK3β/β-catenin signaling. FEBS
Lett. 589:1018–1025. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hong IK, Jeoung DI, Ha KS, Kim YM and Lee
H: Tetraspanin CD151 stimulates adhesion-dependent activation of
Ras, Rac, and Cdc42 by facilitating molecular association between
β1 integrins and small GTPases. J Biol Chem.
287:32027–32039. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roselli S, Kahl RG, Copeland BT, Naylor
MJ, Weidenhofer J, Muller WJ and Ashman LK: Deletion of Cd151
reduces mammary tumorigenesis in the MMTV/PyMT mouse model. BMC
Cancer. 14:5092014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takeda Y, Kazarov AR, Butterfield CE,
Hopkins BD, Benjamin LE, Kaipainen A and Hemler ME: Deletion of
tetraspanin Cd151 results in decreased pathologic angiogenesis in
vivo and in vitro. Blood. 109:1524–1532. 2007. View Article : Google Scholar
|
|
24
|
Palmer TD, Martínez CH, Vasquez C, Hebron
KE, Jones-Paris C, Arnold SA, Chan SM, Chalasani V, Gomez-Lemus JA,
Williams AK, et al: Integrin-free tetraspanin CD151 can inhibit
tumor cell motility upon clustering and is a clinical indicator of
prostate cancer progression. Cancer Res. 74:173–187. 2014.
View Article : Google Scholar :
|
|
25
|
Ranjan A, Bane SM and Kalraiya RD:
Glycosylation of the laminin receptor (α3β1) regulates its
association with tetraspanin CD151: Impact on cell spreading,
motility, degradation and invasion of basement membrane by tumor
cells. Exp Cell Res. 322:249–264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fei Y, Wang J, Liu W, Zuo H, Qin J, Wang
D, Zeng H and Liu Z: CD151 promotes cancer cell metastasis via
integrins α3β1 and α6β1 in vitro. Mol Med Rep. 6:1226–1230.
2012.PubMed/NCBI
|
|
27
|
Deng X, Li Q, Hoff J, Novak M, Yang H, Jin
H, Erfani SF, Sharma C, Zhou P, Rabinovitz I, et al:
Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset
and metastasis. Neoplasia. 14:678–689. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gustafson-Wagner E and Stipp CS: The
CD9/CD81 tetraspanin complex and tetraspanin CD151 regulate α3β1
integrin-dependent tumor cell behaviors by overlapping but distinct
mechanisms. PLoS One. 8:e618342013. View Article : Google Scholar
|
|
29
|
Shiomi T, Inoki I, Kataoka F, Ohtsuka T,
Hashimoto G, Nemori R and Okada Y: Pericellular activation of
proMMP-7 (promatrilysin-1) through interaction with CD151. Lab
Invest. 85:1489–1506. 2005.PubMed/NCBI
|
|
30
|
Yue S, Mu W and Zöller M: Tspan8 and CD151
promote metastasis by distinct mechanisms. Eur J Cancer.
49:2934–2948. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Y, Li YP, Paulson C, Shao JZ, Zhang
X, Wu M and Chen W: Wnt and the Wnt signaling pathway in bone
development and disease. Front Biosci. 19:379–407. 2014. View Article : Google Scholar
|
|
32
|
Valenta T, Hausmann G and Basler K: The
many faces and functions of β-catenin. EMBO J. 31:2714–2736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin CH, Guo Y, Ghaffar S, McQueen P,
Pourmorady J, Christ A, Rooney K, Ji T, Eskander R, Zi X, et al:
Dkk-3, a secreted wnt antagonist, suppresses tumorigenic potential
and pulmonary metastasis in osteosarcoma. Sarcoma. 2013:1475412013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ji T, Guo Y, Kim K, McQueen P, Ghaffar S,
Christ A, Lin C, Eskander R, Zi X and Hoang BH: Neuropilin-2
expression is inhibited by secreted Wnt antagonists and its
down-regulation is associated with reduced tumor growth and
metastasis in osteosarcoma. Mol Cancer. 14:862015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Haydon RC, Deyrup A, Ishikawa A, Heck R,
Jiang W, Zhou L, Feng T, King D, Cheng H, Breyer B, et al:
Cytoplasmic and/or nuclear accumulation of the beta-catenin protein
is a frequent event in human osteosarcoma. Int J Cancer.
102:338–342. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shi GM, Ke AW, Zhou J, Wang XY, Xu Y, Ding
ZB, Devbhandari RP, Huang XY, Qiu SJ, Shi YH, et al: CD151
modulates expression of matrix metalloproteinase 9 and promotes
neoangiogenesis and progression of hepatocellular carcinoma.
Hepatology. 52:183–196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kwon M, Lee SJ, Wang Y, Rybak Y, Luna A,
Reddy S, Adem A, Beaty BT, Condeelis JS and Libutti SK: Filamin A
interacting protein 1-like inhibits WNT signaling and MMP
expression to suppress cancer cell invasion and metastasis. Int J
Cancer. 135:48–60. 2014. View Article : Google Scholar :
|
|
38
|
Liu T, Zhou W, Zhang F, Shi G, Teng H,
Xiao J and Wang Y: Knockdown of IRX2 inhibits osteosarcoma cell
proliferation and invasion by the AKT/MMP9 signaling pathway. Mol
Med Rep. 10:169–174. 2014.PubMed/NCBI
|
